用于移植中的向抗体去除的声流体系统:可实现小体积的治疗性非
Zhiteng Ma1, Riley Kahan2, Jianping Xia1
1Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Science advances
|September 5, 2025
概括
一个新的声流体系统A-START有效地去除小血体中的有害抗体, 这种有针对性的方法可以保护抗体,改善移植结果并降低感染风险.
科学领域:
- 移植免疫学
- 生物医学工程
- 流体动力学
背景情况:
- 抗体中介排斥 (AMR) 是小儿固体器官移植患者移植失败和死亡的主要原因.
- 由于需要大量的血液和随机的抗体去除,现有的异位系统不适合儿童,增加了感染风险.
研究的目的:
- 开发和评估一种新的声流体系统A-START,用于儿童移植中的向性抗体去除.
- 解决目前儿科和小动物模型上的非技术的局限性.
主要方法:
- 开发一个针对小血量设计的声流体系统 (A-START).
- 在敏感的动物皮肤移植模型中进行临床前测试.
- 在保持保护性抗体的同时,选择性去除捐赠者特异性抗体 (DSAs) 的评估.
主要成果:
- A-START只需要240微升的血液才能有效治疗.
- 与传统方法相比,已证明选择性去除DSA的效果有了60%的改善.
- 保持了大约95%的有益抗体,如破伤风抗体.
结论:
- 在儿童移植中,A-START提供了一个有前途,可靠和可扩展的解决方案.
- 该技术有可能显著改善抗药性和其他抗体介导疾病的结果.
- A- START 能够保护抗体,从而降低易受感染患者群体的感染风险.
相关概念视频
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
345
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
345
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
361
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
361